Skip to content
Companies

ChromaCode

High-multiplex PCR tests with cloud analysis

Raised to date

$3.8M

of $5M offered across 1 Form D filing

Still open
$1.1M
Investors
4
Last filed
Feb 5, 2025

About

ChromaCode, Inc. is a biotechnology firm focused on revolutionizing diagnostic testing through its advanced PCR multiplexing technology solutions, enhancing efficiency and scalability in biomarker detection. By integrating cloud computing with traditional PCR methods, ChromaCode provides healthcare and research institutions with innovative approaches to diagnostic problem-solving.

ChromaCode stands out by blending traditional PCR testing with modern cloud computing, creating an accessible, hardware-free, and highly scalable solution.

Funding

  • EquityFiled Feb 5, 2025Form D
    $3.8M/ $5M

Product

HDPCRTM Technology

Diagnostic Technology

HDPCRTM Technology is ChromaCode's flagship product, a sophisticated diagnostic tool that markedly enhances traditional PCR testing. By integrating with the ChromaCode Cloud, it offers users an automated and streamlined testing experience.

  • Less than 24-hour turnaround time
  • Minimal hands-on requirements
  • Automated result interpretation via cloud-based computing

Built for

Clinical laboratories and healthcare facilities

People on file